Praziquantel 600 MG Oral Tablet — RxCUI 198140
RxNorm drug concept · Semantic clinical drug
RxCUI 198140
Semantic clinical drug · SCD
● Current RxNorm concept 2 FDA products
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI198140
Official namePraziquantel 600 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)1,374 prescriptions · 21 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Praziquantel: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Praziquantel treats two types of parasitic worm infections: schistosomiasis, which is caused by blood flukes (a type of flatworm that lives in blood vessels), and liver fluke infec...
- Yes — and that's actually one of the nice things about this medication. The full treatment is three doses taken in a single day, spaced about 4 to 6 hours apart. It's a short, inte...
- Do I really have to take all three doses in one day?
- Don't chew the tablet or hold pieces in your mouth — praziquantel has a very bitter taste that can make you gag or vomit. Swallow it whole with a full glass of water during a meal....
🕸️ Concept Web — How Praziquantel 600 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Praziquantel 600 MG Oral Tablet
RxCUI 198140 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Praziquantel
8628IN
-
Praziquantel
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Biltricide
204264BN
-
Biltricide
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Praziquantel Oral Tablet
373563SCDF -
Praziquantel Oral Product
1161698SCDG -
Praziquantel Pill
1161699SCDG -
Praziquantel Oral Tablet [Biltricide]
369170SBDF -
Biltricide Oral Product
1173661SBDG -
Biltricide Pill
1173662SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Praziquantel Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Praziquantel 600 MG
316578SCDC -
Praziquantel 600 MG Oral Tablet [Biltricide]
208975SBD -
Praziquantel 600 MG [Biltricide]
569619SBDC
-
Praziquantel 600 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Praziquantel 600 MG
SCDC · 316578 -
Praziquantel Oral Tablet
SCDF · 373563 -
Praziquantel Oral Product
SCDG · 1161698 -
Praziquantel Pill
SCDG · 1161699
Brand-Name Concepts
-
Praziquantel 600 MG Oral Tablet [Biltricide]
SBD · 208975 -
Praziquantel 600 MG [Biltricide]
SBDC · 569619 -
Praziquantel Oral Tablet [Biltricide]
SBDF · 369170 -
Biltricide Oral Product
SBDG · 1173661 -
Biltricide Pill
SBDG · 1173662 -
Biltricide
BN · 204264
📦 FDA Products & Package NDCs
2 products · 2 package NDCs
2 package NDCs map to RxCUI 198140 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 49884-0231-83 | 6 TABLET, FILM COATED in 1 BOTTLE (49884-231-83) | PRAZIQUANTEL | Endo USA, Inc. | 2017-11-27 |
| 50419-0747-01 | 6 TABLET, FILM COATED in 1 BOTTLE (50419-747-01) | Biltricide | Bayer HealthCare Pharmaceuticals Inc. | 2011-04-21 |
Observed labelers:
Bayer HealthCare Pharmaceuticals Inc. (1) ·
Endo USA, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$53.0080
Range $53.0080–$53.0080
· middle 50% $53.0080–$53.0080
· 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.